Trudhesa is the First and Only Therapeutic to Use POD® Technology to Deliver Dihydroergotamine Mesylate (DHE)—a Proven, Well-Established Therapeutic—to the Vascular-Rich Upper Nasal Space
Trudhesa is Available Through Trudhesa Direct™, Which Will Provide Hassle-Free Prescribing, Savings and Home Delivery Facilitated by Digital Pharmacy Partners Carepoint Pharmacy and Phil, Inc.
Eligible, Commercially-Insured Patients Will Be Automatically Enrolled in a Patient Savings Program to Obtain Trudhesa
https://finance.yahoo.com/news/impel-neuropharma-announces-trudhesa-dihydroergotamine-123000974.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.